Status:
NOT_YET_RECRUITING
Ketogenic Diet Improves Thrombocytopenia in Cancer Patients
Lead Sponsor:
Baoling Guo
Conditions:
Ketogenic Diet
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
PHASE2
Brief Summary
The main purpose of this study is to evaluate whether dietary intervention through ketogenic diet can prevent or improve chemotherapy related thrombocytopenia in cancer patients.
Detailed Description
In the study, 80 patients with malignant solid tumors undergoing chemotherapy were randomly assigned to the normal diet group, the strict ketogenic diet group, the circulating ketogenic diet group, an...
Eligibility Criteria
Inclusion
- Between the ages of 18 and 90, regardless of gender
- ECOG score ≤ 2 points
- Received or expected to receive radiotherapy and chemotherapy during tumor activity
- Body mass index 19-29
- Conscious and autonomous eaters
Exclusion
- Patients with basic diseases of diabetes
- Complications such as severe liver and kidney dysfunction or digestive tract obstruction, inability to eat
- Those who have a preference for food and have strict requirements for dietary taste
- Disagree to sign informed consent
- Those whose physical conditions are determined by the doctor to be impermissible
Key Trial Info
Start Date :
May 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 10 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06106139
Start Date
May 12 2024
End Date
June 10 2025
Last Update
March 4 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.